Navigation Links
Warner Chilcott Completes Acquisition of P&G's Global Branded Prescription Pharmaceuticals Business
Date:10/30/2009

ity or the delayed-draw term loan facility. The Company's existing $380 million aggregate principal amount of 8 3/4% senior subordinated notes remain outstanding.

The Company

Warner Chilcott is a leading specialty pharmaceutical company currently focused on the women's healthcare, gastroenterology, dermatology and urology segments of the U.S. and Western European pharmaceuticals market. It is a fully integrated company with internal resources dedicated to the development, manufacturing and promotion of its products. WCRX-G

SOURCE Warner Chilcott plc


'/>"/>
SOURCE Warner Chilcott plc
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Warner Chilcott Files Lawsuits for Infringement of DORYX(R) Patent
2. Dr. Mahdi B. Fawzi Joins Warner Chilcott as President, Global Research and Development
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
6. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
7. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
8. QuatRx Completes Patient Enrollment in Phase 3 Study of Ophena(TM) in Women with Postmenopausal Vaginal Syndrome
9. CryoCor Completes Enrollment of Pivotal Clinical Study for Atrial Fibrillation
10. Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
11. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... , Sept. 3, 2015  Cipla, a global ... the everyday needs of all patients, today announced that ... agreements to acquire two US-based companies, InvaGen Pharmaceuticals Inc., ... certain closing conditions, is valued at $550 million and ... from these transactions is over $200 million for the ...
(Date:9/3/2015)... Report Details Cancer ... and Sales Potentials Do ... new report gives you revenue predictions for that industry from ... R&D trends, opportunities, interviews and revenue forecasts. ... sales to 2025 at overall world market, submarket, product and ...
(Date:9/3/2015)... 3, 2015 About self-monitoring blood glucose ... home-based electronic device. It consists of a glucose ... glucose levels through radiowaves from the sensor to ... usage of self-monitoring blood glucose devices can improve ... undergo proper diabetes treatment. Technavio,s analysts ...
Breaking Medicine Technology:Cipla to acquire 100% of generic businesses in US for $550M 2Cipla to acquire 100% of generic businesses in US for $550M 3Cipla to acquire 100% of generic businesses in US for $550M 4Cipla to acquire 100% of generic businesses in US for $550M 5World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 2World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 3World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 4World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 5World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 6World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 7Global Self-monitoring Blood Glucose Devices Market 2015-2019 2
... 2011 / PRNewswire/ -- Fleming Pharmaceuticals, ... iodide product indicated for thyroid protection in radiation emergencies ... necessary to ramp up production to meet increased domestic ... an over-the-counter iodide solution which, when taken orally, saturates ...
... 21, 2011 Scott & White Healthcare today teleconferenced ... to repair an abdominal aortic aneurysm to conference attendees ... in Comparative Education) 2011, is one of the globe,s ... The procedure demonstrated the use of an endograft device ...
Cached Medicine Technology:Fleming Pharmaceuticals Now Ready to Step Up Production of Nuclear Radiation Safeguard, ThyroShield® 2Scott & White Healthcare Broadcasts Live Surgery to Sao Paolo, Brazil 2
(Date:9/4/2015)... ... September 04, 2015 , ... San Francisco ... at CitiDent. CEREC is a newer method for creating restorations through innovative imaging ... by eliminating the need for multiple appointments, CEREC produces restorations with total precision ...
(Date:9/4/2015)... ... ... looking for a quick and convenient way to produce a hot remedy for colds. The ... quick and simple way to brew a hot cup of cold remedy when desired. In ... enhance comfort and health. The invention features a novel design that is lightweight, compact and ...
(Date:9/4/2015)... ... September 04, 2015 , ... The ... place in Hollywood, Florida October 9-10, 2015 at the Diplomat Resort & Spa ... symposium are doctors and researchers at the top of their field and will ...
(Date:9/4/2015)... ... September 04, 2015 , ... Lalonde Gordon ran a 44.64 ... up with victory in the men’s 400 meters final, with an impressive 44.89 seconds ... Championships in San Jose, Costa Rica in August 2015. The 44.64 time is a ...
(Date:9/4/2015)... ... 04, 2015 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has written ... the Pope’s upcoming trip to the United States. , Yisrayl lays out what he says ... Vatican and society is. Yisrayl also provides the meaning of his own name and describes ...
Breaking Medicine News(10 mins):Health News:San Francisco Dentist, Dr. Ben Amini, is Now Offering CEREC Technology at CitiDent 2Health News:Redesigned Packaging for Powdered Medicinal Mix Invented by InventHelp® Client (CBA-2637) 2Health News:Integrative Healthcare Symposium Focus On: The Microbiome Conference Program Announced 2Health News:Lalonde Gordon’s Recipe Brings Home the Gold 2Health News:Lalonde Gordon’s Recipe Brings Home the Gold 3Health News:Yisrayl Hawkins Writes Open Letter to Pope Francis In Light of Approaching U.S. Visit 2
... Dental, a Twin Cities area,group dental practice that ... for 40-years, announced today that it has completed ... from its Boston, Massachusetts-based,administrative services provider, American Dental ... of the settlement of a lawsuit in which,the ...
... Inc. (Nasdaq: IDEV ) announced today that Glenn L. ... Chairman of,the Board of Directors later this year on or ... 15 years at the helm of the company and at ... me to retire from this marvelous,company. Over the years, we ...
... Testosterone appears to protect people against eating disorders, providing ... social influences -- are linked to anorexia and bulimia, ... , An ongoing, six-year study of 538 sets of ... the womb with male twins have lower risk for ...
... Researchers share 5 key tips for parents to ... 3 Child passengers, ages,12 to 16, are ... than younger children,according to a study released today ... risk increases with each teenage year. Conducted,as part ...
... condition,s mania phase, but side effects could be a problem, ... drug commonly used to treat breast cancer may one day ... by people with bipolar disorder, researchers say. , Men and ... lessening of their mania compared to people taking a placebo, ...
... NEW YORK, March 3 With New York physicians,facing ... addition to a projected premium increase, an expected one ... in the Egg, Empire State,Plaza, on Tuesday, March 4th ... a.m. and then march on the Capitol steps by ...
Cached Medicine News:Health News:Park Dental Announces Separation From Its Administrative Service Provider 2Health News:Park Dental Announces Separation From Its Administrative Service Provider 3Health News:Indevus Pharmaceuticals Announces Retirement Plans For Its CEO and Chairman 2Health News:Indevus Pharmaceuticals Announces Retirement Plans For Its CEO and Chairman 3Health News:MSU research indicates testosterone could guard against eating disorders 2Health News:New Research Shows Car Crash Deaths Increase Starting At Age 12 2Health News:New Research Shows Car Crash Deaths Increase Starting At Age 12 3Health News:Breast Cancer Drug Might Treat Bipolar Disorder 2Health News:Breast Cancer Drug Might Treat Bipolar Disorder 3Health News:Attention New York: Please Don't Get Sick on March 4th, Your Doctor Will be in Albany for Malpractice Insurance Reform 2
Straight shafts, 1 x 2 teeth. Wide serrated handle with polished finish. Teeth: 0.3 mm. Most popular size or model....
Serrated handle with polished finish. Non-magnetic. Straight tips: Delicate 11 mm. Most popular size or model....
Straight crisscross serrated tips. Flat handle with holes and polished finish....
1 x 2 teeth, cross serrated 5 mm 60 degree angled platform. Round knurled handle with polished finish....
Medicine Products: